메뉴 건너뛰기




Volumn 9, Issue 5, 2007, Pages 393-400

The role of probiotics in management of irritable bowel syndrome

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PLACEBO; PROBIOTIC AGENT;

EID: 38849122799     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0048-6     Document Type: Review
Times cited : (15)

References (48)
  • 2
    • 0036094268 scopus 로고    scopus 로고
    • Diagnosis of irritable bowel syndrome
    • Olden KW: Diagnosis of irritable bowel syndrome. Gastroenterology 2002, 122:1701-1714.
    • (2002) Gastroenterology , vol.122 , pp. 1701-1714
    • Olden, K.W.1
  • 3
    • 33846423499 scopus 로고    scopus 로고
    • Role of infection in irritable bowel syndrome
    • Spiller RC: Role of infection in irritable bowel syndrome. J Gastroenterol 2007, 42(Suppl 17):41-47.
    • (2007) J Gastroenterol , vol.42 , Issue.SUPPL. 17 , pp. 41-47
    • Spiller, R.C.1
  • 4
    • 33745659814 scopus 로고    scopus 로고
    • Systematic review: The efficacy of treatments for irritable bowel syndrome - a European perspective
    • Tack J, Fried M, Houghton LA, et al.: Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006, 24:183-205.
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 183-205
    • Tack, J.1    Fried, M.2    Houghton, L.A.3
  • 5
    • 34147132358 scopus 로고    scopus 로고
    • Critical evaluation of probiotic activity of lactic acid bacteria and their effects
    • Heczko PB, Strus M, Kochan P: Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol 2006, 57(Suppl 9):5-12.
    • (2006) J Physiol Pharmacol , vol.57 , Issue.SUPPL. 9 , pp. 5-12
    • Heczko, P.B.1    Strus, M.2    Kochan, P.3
  • 6
    • 33846452536 scopus 로고    scopus 로고
    • Is there a role for probiotics in irritable bowel syndrome?
    • Camilleri M: Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis 2006, 38(Suppl 2);S266-S269.
    • (2006) Dig Liver Dis , vol.38 , Issue.SUPPL. 2
    • Camilleri, M.1
  • 7
    • 33750360362 scopus 로고    scopus 로고
    • Bacterial overgrowth as a cause of irritable bowel syndrome
    • Riordan SM, Kim R: Bacterial overgrowth as a cause of irritable bowel syndrome. Curr Opin Gastroenterol 2006, 22:669-673.
    • (2006) Curr Opin Gastroenterol , vol.22 , pp. 669-673
    • Riordan, S.M.1    Kim, R.2
  • 8
    • 0035006468 scopus 로고    scopus 로고
    • Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats
    • Husebye E, Hellstrom PM, Sundler F, et al.: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001, 280:G368-G380.
    • (2001) Am J Physiol Gastrointest Liver Physiol , vol.280
    • Husebye, E.1    Hellstrom, P.M.2    Sundler, F.3
  • 10
    • 0034048222 scopus 로고    scopus 로고
    • Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization
    • Tanaka H, Hashiba H, Kok J, Mierau I: Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization. Appl Environ Microbiol 2000, 66:2502-2512.
    • (2000) Appl Environ Microbiol , vol.66 , pp. 2502-2512
    • Tanaka, H.1    Hashiba, H.2    Kok, J.3    Mierau, I.4
  • 11
    • 0033251402 scopus 로고    scopus 로고
    • Screening of lactic acid bacteria for bile salt hydrolase activity
    • Tanaka H, Doesburg K, Iwasaki T, Mierau I: Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 1999, 82:2530-2535.
    • (1999) J Dairy Sci , vol.82 , pp. 2530-2535
    • Tanaka, H.1    Doesburg, K.2    Iwasaki, T.3    Mierau, I.4
  • 12
    • 0042344991 scopus 로고    scopus 로고
    • Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patiens with Crohn's disease
    • Boudeau J, Glasser AL, Julien S, et al.: Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patiens with Crohn's disease. Aliment Pharmacol Ther 2003, 18:45-56.
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 45-56
    • Boudeau, J.1    Glasser, A.L.2    Julien, S.3
  • 13
    • 0344035326 scopus 로고    scopus 로고
    • Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game
    • Freitas M, Tavan E, Cayuela C, et al.: Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 2003, 95:503-506.
    • (2003) Biol Cell , vol.95 , pp. 503-506
    • Freitas, M.1    Tavan, E.2    Cayuela, C.3
  • 14
    • 0032958362 scopus 로고    scopus 로고
    • Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
    • Mack DR, Michail S, Wei S, et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:G941-G950.
    • (1999) Am J Physiol , vol.276
    • Mack, D.R.1    Michail, S.2    Wei, S.3
  • 15
    • 0038237678 scopus 로고    scopus 로고
    • Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro
    • Mack DR, Ahrne S, Hyde L, et al.: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833.
    • (2003) Gut , vol.52 , pp. 827-833
    • Mack, D.R.1    Ahrne, S.2    Hyde, L.3
  • 17
    • 0034831139 scopus 로고    scopus 로고
    • Probiotic bacteria enhance murine and human intestinal epithelial barrier function
    • Madsen K, Cornish A, Soper P, et al.: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591.
    • (2001) Gastroenterology , vol.121 , pp. 580-591
    • Madsen, K.1    Cornish, A.2    Soper, P.3
  • 18
    • 4644249955 scopus 로고    scopus 로고
    • Wehkamp J, Harder J, Wehkamp K, et al.: NF-kappaB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004, 72:5750-S758.
    • Wehkamp J, Harder J, Wehkamp K, et al.: NF-kappaB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004, 72:5750-S758.
  • 19
    • 0033762339 scopus 로고    scopus 로고
    • Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity
    • Lievin V, Peiffer I, Hudault S, et al.: Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47:646-652.
    • (2000) Gut , vol.47 , pp. 646-652
    • Lievin, V.1    Peiffer, I.2    Hudault, S.3
  • 20
    • 1642555518 scopus 로고    scopus 로고
    • Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50
    • Xiao H, Chen X, Chen M, et al.: Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50. Microbiology 2004, 150:103-108.
    • (2004) Microbiology , vol.150 , pp. 103-108
    • Xiao, H.1    Chen, X.2    Chen, M.3
  • 21
    • 17044456969 scopus 로고    scopus 로고
    • The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
    • Bernet-Camard MF, Lievin V, Brassart D, et al.: The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 1997, 63:2747-2753.
    • (1997) Appl Environ Microbiol , vol.63 , pp. 2747-2753
    • Bernet-Camard, M.F.1    Lievin, V.2    Brassart, D.3
  • 22
    • 17044444528 scopus 로고    scopus 로고
    • Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB
    • Coconnier MH, Lievin V, Bernet-Camard MF, et al.: Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997, 41:1046-1052.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 1046-1052
    • Coconnier, M.H.1    Lievin, V.2    Bernet-Camard, M.F.3
  • 23
    • 15744374565 scopus 로고    scopus 로고
    • Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
    • O'Mahony L, McCarthy J, Kelly P, et al.: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
    • (2005) Gastroenterology , vol.128 , pp. 541-551
    • O'Mahony, L.1    McCarthy, J.2    Kelly, P.3
  • 24
    • 33947324517 scopus 로고    scopus 로고
    • Immune activation in patients with irritable bowel syndrome
    • Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920.
    • (2007) Gastroenterology , vol.132 , pp. 913-920
    • Liebregts, T.1    Adam, B.2    Bredack, C.3
  • 25
    • 14844349149 scopus 로고    scopus 로고
    • Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells
    • Di Giacinto C, Marinaro M, Sanchez M, et al.: Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005, 174:3237-3246.
    • (2005) J Immunol , vol.174 , pp. 3237-3246
    • Di Giacinto, C.1    Marinaro, M.2    Sanchez, M.3
  • 26
    • 2142810997 scopus 로고    scopus 로고
    • DNA from probiotic bacteria modulates murine and human epithelial and immune function
    • Jijon H, Backer J, Diaz H, et al.: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126:1358-73.
    • (2004) Gastroenterology , vol.126 , pp. 1358-1373
    • Jijon, H.1    Backer, J.2    Diaz, H.3
  • 27
    • 33646551486 scopus 로고    scopus 로고
    • Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius
    • O'Hara AM, O'Regan P, Fanning A, et al.: Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006, 118:202-15.
    • (2006) Immunology , vol.118 , pp. 202-215
    • O'Hara, A.M.1    O'Regan, P.2    Fanning, A.3
  • 28
    • 33750239826 scopus 로고    scopus 로고
    • Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells
    • Helwig U, Lammers KM, Rizzello F, et al.: Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 2006, 12:5978-86.
    • (2006) World J Gastroenterol , vol.12 , pp. 5978-5986
    • Helwig, U.1    Lammers, K.M.2    Rizzello, F.3
  • 29
    • 0020665293 scopus 로고
    • Traitement des Colopathies Fonctionnelles - essai en double aveugle de l'ultra - leuvre
    • Maupas JL, Champemont P, Delforge M: Traitement des Colopathies Fonctionnelles - essai en double aveugle de l'ultra - leuvre. Medicine et Chirurgie Digestives 1983, 12:77-79.
    • (1983) Medicine et Chirurgie Digestives , vol.12 , pp. 77-79
    • Maupas, J.L.1    Champemont, P.2    Delforge, M.3
  • 30
    • 0029738351 scopus 로고    scopus 로고
    • Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, double-blind, cross-over trial
    • Halpern GM, Prindiville T, Blankenburg M, et al.: Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996, 91:1579-1585.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1579-1585
    • Halpern, G.M.1    Prindiville, T.2    Blankenburg, M.3
  • 31
    • 0034059773 scopus 로고    scopus 로고
    • Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
    • Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231-1238.
    • (2000) Am J Gastroenterol , vol.95 , pp. 1231-1238
    • Nobaek, S.1    Johansson, M.L.2    Molin, G.3
  • 32
    • 0034767063 scopus 로고    scopus 로고
    • A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
    • Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13:1143-1147.
    • (2001) Eur J Gastroenterol Hepatol , vol.13 , pp. 1143-1147
    • Niedzielin, K.1    Kordecki, H.2    Birkenfeld, B.3
  • 33
    • 33745569311 scopus 로고    scopus 로고
    • Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
    • Whorwell PJ, Altringer L, Morel J, et al.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101:1581-1590.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1581-1590
    • Whorwell, P.J.1    Altringer, L.2    Morel, J.3
  • 34
    • 0037392231 scopus 로고    scopus 로고
    • A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
    • Kim HJ, Camilleri M, McKinzie S, et al.: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17:895-904.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 895-904
    • Kim, H.J.1    Camilleri, M.2    McKinzie, S.3
  • 35
    • 25844477007 scopus 로고    scopus 로고
    • A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
    • Kim HJ, Vazquez Roque MI, Camilleri M, et al.: A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005, 17:687-696.
    • (2005) Neurogastroenterol Motil , vol.17 , pp. 687-696
    • Kim, H.J.1    Vazquez Roque, M.I.2    Camilleri, M.3
  • 36
    • 24344472329 scopus 로고    scopus 로고
    • A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention
    • Kajander K, Hatakka K, Poussa T, et al.: A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22:387-394.
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 387-394
    • Kajander, K.1    Hatakka, K.2    Poussa, T.3
  • 37
    • 27744579575 scopus 로고    scopus 로고
    • Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: A methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study
    • Bittner AC, Croffut RM, Stranahan MC: Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther 2005, 27:755-761.
    • (2005) Clin Ther , vol.27 , pp. 755-761
    • Bittner, A.C.1    Croffut, R.M.2    Stranahan, M.C.3
  • 38
    • 33749170157 scopus 로고    scopus 로고
    • The effects of probiotics on symptoms of irritable bowel syndrome
    • Kim YG, Moon JT, Lee KM, et al.: The effects of probiotics on symptoms of irritable bowel syndrome: Korean J Gastroenterol 2006, 47:413-419.
    • (2006) Korean J Gastroenterol , vol.47 , pp. 413-419
    • Kim, Y.G.1    Moon, J.T.2    Lee, K.M.3
  • 39
    • 0033921870 scopus 로고    scopus 로고
    • Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
    • O'Sullivan MA, O'Morain CA: Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000, 32:294-301.
    • (2000) Dig Liver Dis , vol.32 , pp. 294-301
    • O'Sullivan, M.A.1    O'Morain, C.A.2
  • 40
    • 0036845692 scopus 로고    scopus 로고
    • Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome
    • Sen S, Mullan MM, Parker TJ, et al.: Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002, 47:2615-2620.
    • (2002) Dig Dis Sci , vol.47 , pp. 2615-2620
    • Sen, S.1    Mullan, M.M.2    Parker, T.J.3
  • 41
    • 28944452948 scopus 로고    scopus 로고
    • The efficacy of Lactobacillas reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study
    • Niv E, Naftali T, Hallak R, Vaisman N: The efficacy of Lactobacillas reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind, placebo-controlled, randomized study. Clin Nutr 2005, 24:925-931.
    • (2005) Clin Nutr , vol.24 , pp. 925-931
    • Niv, E.1    Naftali, T.2    Hallak, R.3    Vaisman, N.4
  • 42
    • 23944459103 scopus 로고    scopus 로고
    • The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial
    • Bausserman M, Michail S: The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005, 147:197-201.
    • (2005) J Pediatr , vol.147 , pp. 197-201
    • Bausserman, M.1    Michail, S.2
  • 43
    • 13944255868 scopus 로고    scopus 로고
    • Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
    • Malinen E, Rinttila T, Kajander K, et al.: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005, 100:373-382.
    • (2005) Am J Gastroenterol , vol.100 , pp. 373-382
    • Malinen, E.1    Rinttila, T.2    Kajander, K.3
  • 44
    • 33646570547 scopus 로고    scopus 로고
    • Measuring successful treatment of irritable bowel syndrome: Is "satisfactory relief" enough?
    • Schoenfeld P, Talley NJ: Measuring successful treatment of irritable bowel syndrome: is "satisfactory relief" enough? Am J Gastroenterol 2006, 101:1066-1068.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1066-1068
    • Schoenfeld, P.1    Talley, N.J.2
  • 45
    • 0032485784 scopus 로고    scopus 로고
    • Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures
    • Tuomola EM, Salminen SJ: Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998, 41:45-51.
    • (1998) Int J Food Microbiol , vol.41 , pp. 45-51
    • Tuomola, E.M.1    Salminen, S.J.2
  • 46
    • 33846288886 scopus 로고    scopus 로고
    • Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaccous bacterial compounds
    • Tallon R, Arias S, Bressollier P, Urdaci MC: Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaccous bacterial compounds. J Appl Microbiol 2007, 102:442-451.
    • (2007) J Appl Microbiol , vol.102 , pp. 442-451
    • Tallon, R.1    Arias, S.2    Bressollier, P.3    Urdaci, M.C.4
  • 47
    • 0036130169 scopus 로고    scopus 로고
    • Adhesion of dairy propionibacteria to intestinal epithetial tissue in vitro and in vivo
    • Zarate G, Morata de Ambrosini VI, Chaia AP, Gonzalez SN: Adhesion of dairy propionibacteria to intestinal epithetial tissue in vitro and in vivo. J Food Prot 2002, 65:534-539.
    • (2002) J Food Prot , vol.65 , pp. 534-539
    • Zarate, G.1    Morata de Ambrosini, V.I.2    Chaia, A.P.3    Gonzalez, S.N.4
  • 48
    • 0036972368 scopus 로고    scopus 로고
    • Interaction of lactic acid bacteria with the gut immune system
    • Perdigon G, Maldonado Galdeano C, et al.: Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002, 56(Suppl 4):S21-S26.
    • (2002) Eur J Clin Nutr , vol.56 , Issue.SUPPL. 4
    • Perdigon, G.1    Maldonado Galdeano, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.